Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive loss of motoneurons, motor weakness and death within 1–5 years after disease onset. Therapeutic options remain limited despite a substantial number of approaches that have been tested clinicall...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pitzer, Claudia, Krüger, Carola, Plaas, Christian, Kirsch, Friederike, Dittgen, Tanjew, Müller, Ralph, Laage, Rico, Kastner, Stefan, Suess, Stefanie, Spoelgen, Robert, Henriques, Alexandre, Ehrenreich, Hannelore, Schäbitz, Wolf-Rüdiger, Bach, Alfred, Schneider, Armin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2008
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2639207/
https://ncbi.nlm.nih.gov/pubmed/18835867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awn243
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars